Companies: 10,795·Total market cap: $144.5T
Genetic Technologies Limited

Genetic Technologies Limited

GNTLFOTCHealthcare● Active
$1.00
+$0.00(+0.00%)
Market Cap$1.3B
P/E Ratio
52W High$1
52W Low$1
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Genetic Technologies Limited (GNTLF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001166272 · GNTLF · OTC · as of Jun 9, 2026

Filing snapshot

701
Total Filings
25-NSE
Latest Form
2025-05-12
Most Recent
2000
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001166272 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2024-09-30
Fiscal Year End
Sep 30, 2024
Accession No.
0001493152-24-038693
Primary Document
form20-f.htm
Source: data.sec.gov · CIK 0001166272 · Accession 0001493152-24-038693

Latest Key Filings

6-KQuarterly Report
Quarterly Report
2024-12-12
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
25-NSE25-NSE
25-NSE
2025-05-12
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-12-12
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-12-02
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-11-20
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-10-31
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-10-28
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-10-01
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-10-01
View
20-FAnnual Report (Foreign Issuer)
Annual Report (Foreign Issuer)
2024-09-30
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-09-11
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-08-28
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-08-15
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-07-31
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-07-26
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2024-06-28
View
Showing 1–15 of 701 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001166272  |  Exchange: OTC · Healthcare

Genetic Technologies Limited (OTC: GNTLF) has submitted 701 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2000. As a Healthcare sector company with CIK 0001166272, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Genetic Technologies Limited's most comprehensive regulatory disclosure. The most recent Genetic Technologies Limited 10-K was filed on 2024-09-30 for fiscal year ending 2024. Historical GNTLF 10-K annual reports are available from 2001 through 2024.

Investors researching Genetic Technologies Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

GNTLF SEC Filings · 8 questions

Genetic Technologies Limited (GNTLF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 701 filings and access original documents at no cost. Genetic Technologies Limited's CIK is 0001166272.

GNTLF SEC filingsGenetic Technologies Limited SEC documentsfind GNTLF 10-K